0001062993-24-005986.txt : 20240308 0001062993-24-005986.hdr.sgml : 20240308 20240308163052 ACCESSION NUMBER: 0001062993-24-005986 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240306 FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grant Richard N. Jr. CENTRAL INDEX KEY: 0001821315 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36117 FILM NUMBER: 24734886 MAIL ADDRESS: STREET 1: C/O INTEST CORP STREET 2: 804 EAST GATE DR, SUITE 200 CITY: MT. LAUREL STATE: NJ ZIP: 08054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEST CORP CENTRAL INDEX KEY: 0001036262 STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 222370659 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 804 EAST GATE DR., SUITE 200 CITY: MT. LAUREL STATE: NJ ZIP: 08054 BUSINESS PHONE: 856-505-8800 MAIL ADDRESS: STREET 1: 804 EAST GATE DR., SUITE 200 CITY: MT. LAUREL STATE: NJ ZIP: 08054 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2024-03-06 0001036262 INTEST CORP INTT 0001821315 Grant Richard N. Jr. C/O INTEST CORP 804 EAST GATE DR, SUITE 200 MT. LAUREL NJ 08054 1 1 0 0 President & CEO 0 Common Stock 2024-03-06 4 A 0 17652 0 A 220203 D Common Stock 2024-03-06 4 A 0 17652 0 A 237855 D Employee Stock Option (right to buy) 11.33 2024-03-06 4 A 0 30536 0 A 2034-03-05 Common Stock 30536 30536 D Employee Stock Option (right to buy) 16.06 2033-03-07 Common Stock 16988 16988 D Employee Stock Option (right to buy) 9.76 2032-03-08 Common Stock 25692 25692 D Employee Stock Option (right to buy) 10.62 2031-03-09 Common Stock 112000 112000 D These restricted shares were granted pursuant to the inTEST Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 6, 2025. These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 6, 2027 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 26,478. This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 6, 2025. This option vests in four equal annual installments commencing on March 8, 2024. This option vests in four equal annual installments commencing on March 9, 2023. This option vests in four equal annual installments commencing on March 10, 2022. /s/ Richard N. Grant, Jr. 2024-03-08